In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas

In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas

Bibliographic Details
Main Authors:	Samuele Cazzamalli, Eduard Figueras, Lilla Pethő, Adina Borbély, Christian Steinkühler, Dario Neri, Norbert Sewald
Format:	Article
Language:	English
Published:	American Chemical Society 2018-11-01
Series:	ACS Omega
Online Access:	http://dx.doi.org/10.1021/acsomega.8b02350

Similar Items

In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma
by: Samuele Cazzamalli, et al.
Published: (2018-12-01)

Novel unit B cryptophycin analogues as payloads for targeted therapy
by: Eduard Figueras, et al.
Published: (2018-06-01)

Synthesis and Biological Evaluation of RGD–Cryptophycin Conjugates for Targeted Drug Delivery
by: Adina Borbély, et al.
Published: (2019-04-01)

Conjugates of Cryptophycin and RGD or isoDGR Peptidomimetics for Targeted Drug Delivery
by: Adina Borbély, et al.
Published: (2019-06-01)

Total synthesis and biological evaluation of fluorinated cryptophycins
by: Christine Weiß, et al.
Published: (2012-11-01)

Sortase-Mediated Site-Specific Modification of Interleukin‑2 for the Generation of a Tumor-Targeting Acetazolamide–Cytokine Conjugate
by: Baptiste Gouyou, et al.
Published: (2020-09-01)

A two step synthesis of a key unit B precursor of cryptophycins by asymmetric hydrogenation
by: Benedikt Sammet, et al.
Published: (2011-02-01)

Octreotide Conjugates for Tumor Targeting and Imaging
by: Eduard Figueras, et al.
Published: (2019-05-01)

An Attenuated Targeted-TNF Localizes to Tumors In Vivo and Regains Activity at the Site of Disease
by: Sheila Dakhel, et al.
Published: (2021-09-01)

Acetazolamide in Hydrocephalus Management
by: J Gordon Millichap
Published: (1995-02-01)

Acetazolamide in Vestibulocerebellar Syndrome
by: J Gordon Millichap
Published: (1991-05-01)

Growth Suppression with Acetazolamide
by: J Gordon Millichap
Published: (1997-01-01)

Acetazolamide for Partial Seizures
by: J Gordon Millichap
Published: (1989-01-01)

Effects of Modification of Light Parameters on the Production of Cryptophycin, Cyanotoxin with Potent Anticancer Activity, in <i>Nostoc</i> sp.
by: Alexandros Polyzois, et al.
Published: (2020-12-01)

Acetazolamide in prevention of altitude disease
by: Paweł Choroszewicz, et al.
Published: (2020-05-01)

Acetazolamide Monotherapy for Myoclonic Epilepsy
by: J Gordon Millichap
Published: (1990-11-01)

Acetazolamide in Hypokalemic Periodic Paralysis
by: J Gordon Millichap
Published: (2000-09-01)

Stroke Mimic Caused by Acetazolamide
by: Tiago Manuel Mendes
Published: (2018-02-01)

Rare toxicity of diamox (acetazolamide)
by: Bhatnagar N
Published: (1983-01-01)

Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro and In Vivo Study
by: Rehab Abdelmonem, et al.
Published: (2021-02-01)

Structural Characterization of Daunomycin-Peptide Conjugates by Various Tandem Mass Spectrometric Techniques
by: Adina Borbély, et al.
Published: (2021-02-01)

Acetazolamide Intoxication in an Elderly Patient with Diabetes and Chronic Renal Failure after Cataract Surgery
by: Juliana Maria Kerber, et al.
Published: (2020-01-01)

Role of diamox (acetazolamide) in cataract surgery
by: Maria D, et al.
Published: (1970-01-01)

Acetazolamide for the treatment of acute mountain sickness
by: Luciano Tapia, et al.
Published: (2019-12-01)

Erythema multiforme secondary to acetazolamide (Diamox)
by: Nayak A, et al.
Published: (1981-01-01)

Familial Paroxysmal Ataxia: Acetazolamide Therapy
by: J Gordon Millichap
Published: (1992-05-01)

Role Of Acetazolamide In The Treatment Of Partial Epilepsy
by: Iype T, et al.
Published: (2000-01-01)

In vivo antitumor effects of carboxymethyl chitosan-conjugated triptolide after oral administration
by: Huahui Zeng, et al.
Published: (2020-01-01)

Synthesis of marine natural products. part I, Cryptophycins-1, -3, -4, -24, and -29, part II, Polycavernoside A
by: Robarge, Lonnie A.
Published: (2012)

Fabrication of Transgelosomes for Enhancing the Ocular Delivery of Acetazolamide: Statistical Optimization, In Vitro Characterization, and In Vivo Study
by: Eman A. Mazyed, et al.
Published: (2020-05-01)

Comment on “Acetazolamide Intoxication in an Elderly Patient with Diabetes and Chronic Renal Failure after Cataract Surgery”
by: Michael H. Schwenk
Published: (2021-01-01)

Pharmacological potential of acetazolamide in traumatic intracranial hypertension
by: López-Cepeda Daniela, et al.
Published: (2018-01-01)

Mechanism of action of acetazolamide and idiopathic intracranial hypertension
by: J. Gordon Millichap, et al.
Published: (2015-02-01)

Topical delivery of acetazolamide by encapsulating in mucoadhesive nanoparticles
by: Satish Manchanda, et al.
Published: (2017-11-01)

Response to acetazolamide in a patient with tumoural calcinosis
by: Venecia Landini-Enríquez, et al.
Published: (2015-09-01)

Genetic control of the teratogenic response to acetazolamide in mice
by: Biddle, Frederick Gordon
Published: (2011)

ACETAZOLAMIDE IN PEDIATRIC NEUROLOGY: HISTORY AND PERSPECTIVE OF CILNICAL USE
by: A.N. Boyko, et al.
Published: (2006-03-01)

Intraocular and intracranial pressure in glaucoma patients taking acetazolamide.
by: Allison R Loiselle, et al.
Published: (2020-01-01)

Topiramate Compared to Acetazolamide in Treatment of Idiopathic Intracranial Hypertension
by: J Gordon Millichap
Published: (2007-11-01)

Acetazolamide-Induced agranulocytosis in a patient with pseudotumor cerebri
by: Faruk Incecik, et al.
Published: (2020-01-01)

Cannot write session to /tmp/vufind_sessions/sess_mnsqg0qv39dar41o96l0morhfa